Digest Network Come funziona
Network
/
Società
Pf
Non verificato

Pfizer Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

125 comunicati stampa

Guarda tutti i comunicati
08/06/2026
Industria
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Medicina - Varie
U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
06/06/2026
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Web e Social Network
Eventi
Fiere
Industria
Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA Berobenatide
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
01/06/2026
Web e Social Network
Eventi
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
31/05/2026
Eventi
Oncologia
Salute
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
30/05/2026
Mercato del lavoro
Eventi
Fiere
Industria
Scienza
Biotecnologia
Medicina - Varie
Medicina nucleare
Salute
Farmaceutica
Oncologia
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
29/05/2026
Scienza
Igiene alimentare
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Sanità
Oncologia
Eventi
Industria
Seven-Year Analysis from Pfizer’s LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
28/05/2026
Oncologia
Salute
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
Mercato del lavoro
Industria
Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
27/05/2026
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Web e Social Network
Eventi
Industria
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
27/05/2026
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Web e Social Network
Eventi
Industria
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0
20/05/2026
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results
Fonte
Pfizer Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0